Sean J. Pittock

Active 2000–2025

Also published as
Sean J Pittock
279
Papers
48,598
Citations
113
h-index
267
i10-index

Citations

Citations per year for Sean J. Pittock1986: 1 citations1997: 5 citations2001: 1 citations2002: 7 citations2003: 8 citations2004: 15 citations2005: 37 citations2006: 107 citations2007: 160 citations2008: 222 citations2009: 293 citations2010: 275 citations2011: 339 citations2012: 400 citations2013: 389 citations2014: 270 citations2015: 323 citations2016: 216 citations2017: 306 citations2018: 254 citations2019: 1,141 citations2020: 1,492 citations2021: 1,618 citations2022: 1,348 citations2023: 1,259 citations2024: 2,101 citations2025: 810 citations2026: 2 citations1987–1996: no citations, so these years are not shown1998–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,972 citing papers, 22.7% of this breakdownGermany: 717 citing papers, 8.2% of this breakdownUnited Kingdom: 702 citing papers, 8.1% of this breakdownChina: 596 citing papers, 6.9% of this breakdownItaly: 466 citing papers, 5.4% of this breakdownFrance: 435 citing papers, 5% of this breakdownJapan: 349 citing papers, 4% of this breakdownSpain: 332 citing papers, 3.8% of this breakdownCanada: 329 citing papers, 3.8% of this breakdownAustralia: 252 citing papers, 2.9% of this breakdownAustria: 224 citing papers, 2.6% of this breakdownSwitzerland: 213 citing papers, 2.4% of this breakdown
0%22.7%Other 24.2%

Fields

  • Medicine86.2%
  • Neuroscience5%
  • Biochemistry, Genetics and Molecular Biology4.7%
  • Immunology and Microbiology3.3%
  • Health Professions0.2%
  • Engineering0.2%
  • Other0.4%

Topics

  • Multiple Sclerosis Research Studies16.5%
  • Peripheral Neuropathies and Disorders12.9%
  • Autoimmune Neurological Disorders and Treatments10.4%
  • Systemic Lupus Erythematosus Research3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms2.5%
  • Neurogenesis and neuroplasticity mechanisms1.4%
  • Other52.9%

Coauthors

All papers

Open in search
  1. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2023 cited by 1,130

  2. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , - The Lancet 2019 cited by 717

  3. Myelin-oligodendrocyte glycoprotein antibody-associated disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Krzysztof Selmaj, Aksel Sıva, Bruno Stankoff, Mar Tintoré, Anthony Traboulsee, Patrick Waters, Emmanuelle Waubant, Brian G. Weinshenker, Tobias Derfuß, Sandra Vukusic, Bernhard Hemmer - The Lancet Neurology 2021 cited by 517

  4. Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2019 cited by 846

  5. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

    Authors: , , , , , , , - The Lancet 2004 cited by 3,227

  6. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2021 cited by 521

  7. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management

    Authors: , , , , , , , , - Frontiers in Neurology 2022 cited by 299

  8. Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2018 cited by 760

  9. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

    Authors: , , , , - The Journal of Experimental Medicine 2005 cited by 2,273

  10. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody

    Authors: , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 366

  11. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients

    Authors: , , , , , , , , , , , , - Annals of Neurology 2017 cited by 541

  12. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy

    Authors: , , , , , , - JAMA Neurology 2016 cited by 550

  13. Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2023 cited by 191

  14. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide

    Authors: , , , , , , , , , , , , , , , - Frontiers in Neurology 2020 cited by 398

  15. Autoimmune Encephalitis Misdiagnosis in Adults

    Authors: , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2022 cited by 282

  16. The spectrum of neuromyelitis optica

    Authors: , , , , - The Lancet Neurology 2007 cited by 2,177

  17. Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing

    Authors: , , , , , , , , , , , , , - JAMA Neurology 2021 cited by 214

  18. Significance of Myelin Oligodendrocyte Glycoprotein Antibodies in CSF

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2022 cited by 81

  19. International multicenter examination of MOG antibody assays

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology Neuroimmunology & Neuroinflammation 2020 cited by 278

  20. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders

    Authors: , , , , , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 407

  21. Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Ophthalmology 2018 cited by 400

  22. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody

    Authors: , , , , , , , , , , , , , , , , , , , , , - JAMA Neurology 2018 cited by 373

  23. Expanded phenotypes and outcomes among 256 LGI 1/ CASPR 2‐ I g G –positive patients

    Authors: , , , , , , , , , , , , - Annals of Neurology 2017 cited by 364

  24. Hope for patients with neuromyelitis optica spectrum disorders — from mechanisms to trials

    Authors: , , - Nature Reviews Neurology 2021 cited by 128